| Financial Year |
March 31 2023 |
| Monetary Funds |
15,824,959,339.53 |
| Held-for-trading Financial Assets |
1,300,000,000.00 |
| Notes Receivable |
84,482,859.77 |
| Accounts Receivable |
29,148,912,798.23 |
| Advances to Suppliers |
1,492,260,987.74 |
| Other Receivables |
2,090,070,923.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
53,082,069.48 |
| Dividend Receivable |
876,177.10 |
| Inventories |
1,125,091,812.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
227,700,000.00 |
| Other Current Assets |
2,544,333,857.64 |
| Total Current Assets |
78,387,931,285.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
345,267,145.02 |
| Long-term Equity Investment |
1,406,017,786.00 |
| Investment Properties |
21,360,061.63 |
| Fixed Assetes |
11,622,377,454.85 |
| Under-construction Projects |
5,735,784,171.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,609,599,966.73 |
| R&D expenses |
7,950,649.04 |
| Goodwill |
23,578,079.97 |
| Long-Term Deferred and Prepaid Expenses |
132,056,440.01 |
| Deferred Income Tax Assets |
417,243,180.62 |
| Other Non-Current Assets |
7,594,244,963.37 |
| Sub-Total of Non-Current Assets |
30,912,355,111.36 |
| Total Assets |
109,300,286,396.87 |
| Short-Term Loans |
7,866,373,402.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,370,247,824.36 |
| Accounts Payable |
41,139,029,162.54 |
| Accounts Received In Advance |
31,381,041.05 |
| Employee Compensation Payable |
54,436,264.42 |
| Taxes Payable |
683,629,792.62 |
| Interest Payable |
-- |
| Dividend Payable |
13,703,099.84 |
| Other payables |
3,515,539,624.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,599,439,918.70 |
| Other Current Liabilities |
2,341,367,861.43 |
| Sub-Total of Current Liabilities |
78,696,041,481.72 |
| Long-term Loans |
17,918,472,084.57 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
587,103,412.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
38,420,763.16 |
| Deferred Income Tax Liabilities |
7,362,406.08 |
| Other Non-Current Liabilities |
79,921,119.34 |
| Sub-Total of Non-Current Liabilities |
19,284,493,445.25 |
| Total Liabilities |
97,980,534,926.97 |
| Paid-In Capital(Or Share Stock) |
3,393,714,625.00 |
| Capital Surplus |
1,373,263,924.79 |
| Surplus Reserve |
227,130,116.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,804,737,606.16 |
| Minority Stockholder's Interest |
1,068,725,151.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,251,026,317.91 |
| Owner's Equity（Stockholder's Equity） |
11,319,751,469.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
109,300,286,396.87 |
